News
News Articles 1 - 10 of 160
Mar
Read more
The FSRH Clinical Effectiveness Unit is currently updating their guideline on the safety of contraceptive methods (the UKMEC). The UKMEC considers safety of use of contraceptive methods by individuals with a variety of personal characteristics or medical conditions: UK Medical Eligibility Criteria for Contraceptive Use.
They would like to secure some input from a liver disease expert to advise their Guideline Development Group and they would be very grateful for any help BASL members can give if someone is willing to assist them.
They are seeking a topic expert with a broad knowledge of liver disease who could advise our Guideline Development Group on the following areas:
- Cholestasis
- Viral hepatitis
- Cirrhosis
- Liver tumours
It would involve an initial meeting with their Clinical Director and systematic reviewer to consider the evidence (about an hour) in April/early May. They would also ask the topic expert to attend, if possible, part of their UKMEC Guideline Development Group meeting, which is taking place on the afternoon of Monday 9 June 2025 (for a slot of about 1 hour). They would also ask the expert to review relevant sections of draft text for the guideline subsequently, if it is agreed that revisions are needed.
Participating in this project offers an opportunity to work with leading UK and international experts on national guidance as well as those from other specialties, gain experience in guideline development and be acknowledged for your contribution in the final guideline document.
The topic expert must be a consultant clinician currently working in the specified field. The topic expert must also be in good standing with the relevant professional body and not subject to fitness to practise proceedings. Previous experience in the development of guidelines would be welcome but is not essential.
Please note the role isn’t remunerated.
They would be delighted if one of our members would be able to help.
If you are interested in assisting please contact: ceu@fsrh.org .
Mar
Read more
There are challenges that are unique to female patients as they go through the organ transplant process. A research team at the University of Edinburgh are carrying out a study, funded by NHS Blood and Transplant, to gain a greater understanding of their experiences and needs at different stages of this process and identify where and how improvements can be made to address these.
They are inviting healthcare professionals who treat or support transplant patients to express interest in participating in an online workshop. At the workshop, they will present findings from their qualitative survey on female transplant patients' experiences and needs, asking staff to work together to discuss the findings and identify key priority areas for action to ensure that these are addressed to improve the experience for female patients.
Please click on the link below to find out more about the study and what is involved in taking part:
https://app.onlinesurveys.jisc.ac.uk/s/edinburgh/workshop-for-transplant-staff
Feb
Read more
The British Liver Transplant Group (BLTG) is supporting the UK Organ Donation and Transplant Research Network (UKODTRN) to obtain as broad and complete a picture of all PPIE activity in the transplant field and ask that you complete their survey below.
Meaningful patient and public involvement and engagement (PPIE) is essential for our research. The UKODTRN is conducting a survey to map PPIE activity and infrastructure across the UK in the field of organ donation and transplantation research to ensure it is accessible, useful and relevant to our research community.
We would love to hear your views. Please click on the link below to complete the survey, which should take no longer than 10 minutes.
Take part in the survey > Here .
Many thanks,
UKODTRN
Feb
Read more
The Institute of Alcohol Studies have published a new video explaining the impact of alcohol on our healthcare services.
The video features Julia Sinclair, Professor of Addiction Psychiatry and Chair of the RCPsych Addiction Faculty, Dr Dominique Florin, Medical Director of the Medical Council on Alcohol and Sir Ian Gilmore, Profess or of Hepatology and Chair of the AHA and the MCA, and explores service fragmentation, the consequences of underfunding, and the steps needed to rebuild effective pathways to care. It makes the case for a national alcohol strategy to ensure that people experiencing alcohol dependence receive the support they need.
View on YouTube here > The Impact of Alcohol on our Healthcare Services: Explained.
Or on the Institute of Alcohol Studies website.
Feb
Read more
Following the recent round of nominations for new members to join the BLNA committee, there are more than 4 candidates for the 4 available posts and therefore a vote by the BASL BLNA membership will now take place.
BASL BLNA members can take part in the voting and today (11th February 2025) these members have been sent a communication containing the voting link.
Members can vote for up to 4 candidates and your candidates are:
• Sara Bardell
• Katharine Caddick
• Bryony Chapman
• Grace Clarke
• Megan De Los Reyes
• Rebekah Hill
• Teesha Joshy
• Laura Kent
• Amy Teague
• Ane Zamalloa
The deadline for voting is 09:00hrs on Monday 3rd March 2025. The results with be announced in March 2025.
Please contact admin@basl.org.uk if you have not received your voting link.
Feb
Read more
Calling all innovators in Cancer Surgery
BASO~ACS proudly announces the opening of submissions for 2025 round of the BASO/Rosetrees Research Grants in Cancer Surgery, in partnership with esteemed Rosetrees Trust.
They are seeking innovative research projects in surgical oncology that will develop further towards Clinical Translation. They invite multidisciplinary applications and ones that demonstrate an important improvement in delivery of cancer care or improvement in surgical treatment.
Up to £50,000 is up for grabs! This generous amount will be divided among one or more deserving applicants, based on the excellence of submissions received.
Successful projects will be eligible for inclusion in the NIHR Portfolio. Plus, we encourage applicants to seek support from the esteemed Royal College of Surgeons of England Surgical SITU Interventional Trials Unit (SITU).
Submission closes on 2nd May 2025.
For information on the grant process, eligibility, and to apply, visit BASO Website or email us at admin@baso.org.uk .
Jan
Read more
Pabrinex IV will be out of stock from July/ August 2024 until September 2025, due to supply issues relating to manufacturing regulations issued by the EU. Pabrinex IM will be permanently discontinued from December 2024. Pabrinex is only used in the UK, with thiamine IV/ IM being routinely used globally.
Licensed generic vitamins B+ C intravenous injections are now available in the UK for use.We also now have a licensed IV/ IM generic thiamine here in the UK. This can be used as an alternative to Pabrinex in people at high risk of Wernicke’s encephalopathy for treatment and prevention.
The licensed dosing may differ to the unlicensed versions we have been using however matches the amount of thiamine in Pabrinex. The following, including dosing recommendations, has been updated published online by the DHSC Specialist Pharmacy Service.
Clinical decisions and discussions should be sought when choosing between thiamine and the generic Vitamins B + C injections. There will be some patients that need the extra vitamins in the Vitamins B + C injections, however it is reassuring that the rest of the world uses IV thiamine. Cost effective prescribing is also recommended. We are also awaiting the alcohol management guideline, which should be out later in the year.
Joanna Henry, Network Lead BHPG, Gastroenterology Directorate Pharmacist, Liverpool University Hospitals NHS Trust
Sital Shah, Chair British Hepatology Pharmacy Group , Consultant Pharmacist, King’s College Hospital, London
Pabrinex spc Pabrinex Intramuscular High Potency Injection - Summary of Product Characteristics (SmPC) - (emc)
Thiamine spc Thiamine Hydrochloride 50 mg/ml solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Generic Vitamin B+ C : Public Assessment Report
Jan
Read more
Exciting Announcement!!!
I am delighted to announce that Frontline Gastroenterology (FG, fg.bmj.com) will become the official journal partner of BASL!! There has been a desire to set-up a BASL journal for a number of years, but there have always been challenges that have prevented this, the predominant one being the initial set up costs. Productive discussions were started with FG in mid-to late 2024 and it soon became apparent that the aspirations of FG and BASL aligned closely.
FG will remain a broadly cross subspecialty journal, publishing high quality gastroenterology, hepatology, and nutrition original research and reviews, but there is a clear and strong focus to develop and encourage the submission and publication of liver related articles and release special issues as a major strategic goal of the journal as it aims to grow and increase its impact factor and metrics.
I am grateful to the FG Editor in Chief Dr Philip Smith and the senior publisher at BMJ group for their enthusiasm, flexibility and support in setting this up.
Dr Philip Smith states, "I am delighted that BASL and FG are affiliating. I am firmly committed to publishing the very best frontline Hepatology content that is submitted to FG from around the globe, and have a fantastic Hepatology Associate Editor team (including BASL representation) who are striving to do the same. Working together with BASL is a huge positive for both FG and BASL and I am very excited to see what the future holds. I am grateful to the BASL team and Dr Tim Cross, BASL President for helping to make this happen. I will be proud to see the BASL logo within the journal going forward!"
We very much look forward to working together in the future and will strive to deliver high quality articles and original research to better serve our patients and membership.
Tim Cross
BASL President
Jan
Read more
NICE is developing a guideline on Non-alcoholic fatty liver disease/Metabolic dysfunction-associated Steatohepatitis (NAFLD/MASH).
They are seeking a topic advisor who will attend all meetings and contribute expertise throughout the development process.
This is an online application process and details related to this role can be found here: http://healthjobsuk.com/job/v6894128
Online applications close on 20 January 2025.
Dec
Read more
The 2025 Guts UK/Dr Falk Awards are now open to submissions.
These awards recognise the achievements of those who bring new insight to gastroenterology, pancreatology and hepatology, and the collaboration that furthers patient care. They are also an opportunity to achieve national recognition as well as financial support for career progression.
Visit the Guts UK/Dr Falk Awards 2025 webpage to learn more about the 7 different prize categories, and make sure to submit your application by Monday 17th February 2025 at 5pm.
Any queries can directed to research@gutscharity.org.uk .
